Stock comparison
DEXCOM INC is 22.8x more valuable than KESTRA MEDICAL TECHNOLOGIES, LTD. by market capitalization ($33.92 B vs $1.49 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
DXCM is larger
DEXCOM INC is 22.8x more valuable than KESTRA MEDICAL TECHNOLOGIES, LTD. by market capitalization ($33.92 B vs $1.49 B).
Market value leader
DXCM
DEXCOM INC is 22.8x more valuable than KESTRA MEDICAL TECHNOLOGIES, LTD. by market capitalization ($33.92 B vs $1.49 B).
Revenue leader
DXCM
KMTS: $59.81M vs DXCM: $4.66B.
Profit leader
DXCM
KMTS: -$113.81M vs DXCM: $836.30M.
Margin leader
DXCM
KMTS: -190.3% vs DXCM: 17.9% net margin.
| Metric | KMTS | DXCM |
|---|---|---|
| Market cap | $1.49 B | $33.92 B |
| US-listed rank | #2354 | #438 |
| Revenue (latest FY) | $59.81M | $4.66B |
| Net income (latest FY) | -$113.81M | $836.30M |
| Net margin | -190.3% | 17.9% |
| P/E (trailing FY) | - | 40.6x |
| SEC filings | 105 | 2,566 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
DEXCOM INC is 22.8x more valuable than KESTRA MEDICAL TECHNOLOGIES, LTD. by market capitalization ($33.92 B vs $1.49 B).
In their latest fiscal years, KESTRA MEDICAL TECHNOLOGIES, LTD. reported $59.81M in revenue while DEXCOM INC reported $4.66B.
Full pages: KESTRA MEDICAL TECHNOLOGIES, LTD. and DEXCOM INC, or browse the full rankings.